- Home
- KNSA vs WT Comparison
KNSA vs WT Comparison
Compare KNSA & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- WT
- Stock Information
- Founded
- KNSA 2015
- WT 1985
- Country
- KNSA United Kingdom
- WT United States
- Employees
- KNSA N/A
- WT N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- WT Investment Bankers/Brokers/Service
- Sector
- KNSA Health Care
- WT Finance
- Exchange
- KNSA Nasdaq
- WT Nasdaq
- Market Cap
- KNSA 1.3B
- WT 1.4B
- IPO Year
- KNSA 2018
- WT N/A
- Fundamental
- Price
- KNSA $18.73
- WT $9.81
- Analyst Decision
- KNSA Strong Buy
- WT Buy
- Analyst Count
- KNSA 5
- WT 8
- Target Price
- KNSA $36.60
- WT $12.28
- AVG Volume (30 Days)
- KNSA 469.7K
- WT 2.0M
- Earning Date
- KNSA 02-26-2025
- WT 01-31-2025
- Dividend Yield
- KNSA N/A
- WT 1.23%
- EPS Growth
- KNSA N/A
- WT N/A
- EPS
- KNSA N/A
- WT 0.31
- Revenue
- KNSA $384,098,000.00
- WT $407,884,000.00
- Revenue This Year
- KNSA $60.05
- WT $26.13
- Revenue Next Year
- KNSA $36.74
- WT $6.92
- P/E Ratio
- KNSA N/A
- WT $31.31
- Revenue Growth
- KNSA 54.41
- WT 23.04
- 52 Week Low
- KNSA $16.56
- WT $6.67
- 52 Week High
- KNSA $28.15
- WT $12.45
- Technical
- Relative Strength Index (RSI)
- KNSA 38.56
- WT 37.38
- Support Level
- KNSA $18.27
- WT $9.07
- Resistance Level
- KNSA $19.05
- WT $9.72
- Average True Range (ATR)
- KNSA 0.61
- WT 0.26
- MACD
- KNSA -0.05
- WT -0.01
- Stochastic Oscillator
- KNSA 34.42
- WT 42.75
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models, and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime.